OPKO Health Receivables 2010-2024 | OPK

OPKO Health receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
OPKO Health Annual Receivables
(Millions of US $)
2023 $123
2022 $127
2021 $260
2020 $286
2019 $135
2018 $144
2017 $166
2016 $220
2015 $194
2014 $20
2013 $20
2012 $21
2011 $13
2010 $12
2009 $9
OPKO Health Quarterly Receivables
(Millions of US $)
2024-06-30 $105
2024-03-31 $111
2023-12-31 $123
2023-09-30 $117
2023-06-30 $211
2023-03-31 $121
2022-12-31 $127
2022-09-30 $123
2022-06-30 $158
2022-03-31 $213
2021-12-31 $260
2021-09-30 $255
2021-06-30 $266
2021-03-31 $320
2020-12-31 $286
2020-09-30 $242
2020-06-30 $214
2020-03-31 $132
2019-12-31 $135
2019-09-30 $141
2019-06-30 $148
2019-03-31 $144
2018-12-31 $144
2018-09-30 $157
2018-06-30 $153
2018-03-31 $159
2017-12-31 $166
2017-09-30 $234
2017-06-30 $252
2017-03-31 $239
2016-12-31 $220
2016-09-30 $224
2016-06-30 $213
2016-03-31 $204
2015-12-31 $194
2015-09-30 $190
2015-06-30 $27
2015-03-31 $19
2014-12-31 $20
2014-09-30 $21
2014-06-30 $23
2014-03-31 $20
2013-12-31 $20
2013-09-30 $21
2013-06-30 $22
2013-03-31 $21
2012-12-31 $21
2012-09-30 $19
2012-06-30 $16
2012-03-31 $16
2011-12-31 $13
2011-09-30 $13
2011-06-30 $16
2011-03-31 $14
2010-12-31 $12
2010-09-30 $13
2010-06-30 $12
2010-03-31 $12
2009-12-31 $9
2009-09-30 $1
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.072B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.197B 25.52
Intuitive Surgical (ISRG) United States $190.823B 99.77
Alcon (ALC) Switzerland $45.517B 32.04
IQVIA Holdings (IQV) United States $39.384B 21.70
Edwards Lifesciences (EW) United States $39.340B 24.98
IDEXX Laboratories (IDXX) United States $35.808B 42.17
DexCom (DXCM) United States $27.463B 41.36
Waters (WAT) United States $22.607B 33.43
SONOVA HOLDING (SONVY) Switzerland $22.062B 0.00
STERIS (STE) Ireland $21.899B 25.21
Hologic (HOLX) United States $18.440B 19.46
Sysmex ADR (SSMXY) Japan $12.915B 40.50
Fresenius Medical Care AG KGaA (FMS) Germany $12.552B 12.89
Globus Medical (GMED) United States $11.102B 28.27
Penumbra (PEN) United States $9.290B 91.00
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.654B 41.87
Glaukos (GKOS) United States $7.887B 0.00
PROCEPT BioRobotics (PRCT) United States $5.083B 0.00
Integer Holdings (ITGR) United States $4.679B 26.52
Inari Medical (NARI) United States $3.123B 0.00
Veracyte (VCYT) United States $3.014B 90.44
TransMedics (TMDX) United States $2.991B 94.80
LivaNova (LIVN) United Kingdom $2.813B 16.24
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Elekta AB (EKTAY) Sweden $2.304B 18.77
Tandem Diabetes Care (TNDM) United States $2.060B 0.00
Integra LifeSciences Holdings (IART) United States $1.964B 10.26
RxSight (RXST) United States $1.867B 0.00
Alphatec Holdings (ATEC) United States $1.375B 0.00
Artivion (AORT) United States $1.210B 80.19
Pulse Biosciences (PLSE) United States $1.155B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.951B 16.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.764B 0.00
IRadimed (IRMD) United States $0.727B 39.28
Pacific Biosciences Of California (PACB) United States $0.670B 0.00
SiBone (SIBN) United States $0.664B 0.00
Mesa Laboratories (MLAB) United States $0.646B 15.23
Paragon 28 (FNA) United States $0.637B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.516B 0.00
CVRx (CVRX) United States $0.384B 0.00
Tactile Systems Technology (TCMD) United States $0.383B 20.73
Semler Scientific (SMLR) United States $0.379B 25.43
Delcath Systems (DCTH) United States $0.318B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
AngioDynamics (ANGO) United States $0.302B 0.00
Inogen (INGN) United States $0.262B 0.00
Sight Sciences (SGHT) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Atossa Genetics (ATOS) United States $0.204B 0.00
Accuray (ARAY) United States $0.199B 0.00
Nevro (NVRO) United States $0.198B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.125B 0.00
Sensus Healthcare (SRTS) United States $0.116B 17.19
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Rapid Micro Biosystems (RPID) United States $0.055B 0.00
Accelerate Diagnostics (AXDX) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Biosig Technologies (BSGM) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00